Effects of intravitreal bevacizumab treatment on proliferative retinopathy in a patient with cerebroretinal vasculopathy

Journal of Neurology

Volumn 257, Issue 7, 2010, Pages 1213-1214

  Kernt, Marcus ^a   Gschwendtner, Andreas ^a   Neubauer, Aljoscha S ^a   Dichgans, Martin ^a   Haritoglou, Christos ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ADULT; ANTERIOR EYE SEGMENT; CASE REPORT; CEREBRORETINAL VASCULOPATHY; COGNITIVE DEFECT; DRUG EFFECT; EPILEPSY; EYE EXAMINATION; FOLLOW UP; HEADACHE; HEMIPARESIS; HUMAN; LETTER; MALE; OPHTHALMOSCOPY; OPTIC DISK; PERSONALITY DISORDER; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA HEMORRHAGE; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; SLIT LAMP; VASCULAR DISEASE; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CEREBROVASCULAR DISORDERS; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RETINA; RETINAL ARTERY; RETINAL DISEASES; RETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VITREOUS BODY;

EID: 77954384312     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5500-0     Document Type: Letter

References (8)

1. A Richards AM van den Maagdenberg JC Jen D Kavanagh P Bertram D Spitzer, et al. 2007 C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy Nat Genet 39 9 1068 1070 10.1038/ng2082 1:CAS:528:DC%2BD2sXps12gtL0%3D 17660820
2. Ophoff RA, DeYoung J, Service SK, Joosse M, Caffo NA, Sandkuijl LA et al (2001) Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-21.3. Am J Hum Genet Aug; 69(2):447-53
3. CM Andreoli JW Miller 2007 Anti-vascular endothelial growth factor therapy for ocular neovascular disease Curr Opin Ophthalmol 18 6 502 508 10.1097/ICU.0b013e3282f0ca54 18163003
4. S Moradian H Ahmadieh M Malihi M Soheilian MH Dehghan M Azarmina 2008 Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy Graefes Arch Clin Exp Ophthalmol 246 12 1699 1705 10.1007/s00417-008-0914-4 1:CAS:528:DC%2BD1cXhtlart7nF 18696095
5. TA Ciulla PJ Rosenfeld 2009 Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration Curr Opin Ophthalmol 20 3 158 165 10.1097/ICU.0b013e32832d25b3 19417570
6. AS Neubauer D Kook C Haritoglou SG Priglinger A Kampik MW Ulbig L Ceklic 2007 Bevacizumab and retinal ischemia Ophthalmology 114 11 2096 10.1016/j.ophtha.2007.05.057 17980746
7. EJ Chung MI Roh OW Kwon HJ Koh 2008 Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema Retina 28 7 957 963 10.1097/IAE.0b013e3181754209 18698297
8. M Bonini-Filho RA Costa D Calucci R Jorge LA Melo Jr IU Scott 2009 Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study Am J Ophthalmol 147 6 1022 1030 10.1016/j.ajo.2009.01.009 1:CAS:528:DC%2BD1MXmtlOlt78%3D 19327746